Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2013164403
Up to date per 04.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2013164403
Title / Product Name
Anti-P-Selektin-Antikörper und Verfahren zu ihrer Verwendung für die Behandlung von Entzündungserkrankungen
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2013164403
EP Publication Number
2662091
E-Number
1031691
Language
EN
PCT Number
-
Publication Date
13.11.2013 A
22.08.2018 B1
Registration Date
22.08.2018
AT Publication Date
15.09.2018
Application Date
30.11.2007
Registration Number
-
Priorities
01.12.2006
US
872170 P
IPC
A61K 39/395 20060101AFI20140205BHEP
Maximum Duration of Protection
30.11.2027
Owner
Novartis AG
Lichtstrasse 35
4056 Basel
CH
Oklahoma Medical Research Foundation
825 N.E. 13th Street
73104 Oklahoma City, OK
US
Representative
Representative
Schwarz & Partner Patentanwälte OG
Wipplingerstraße 30
1010 Wien
AT
Inventor
McEver, Rodger P.
1716 Guildford Lane
Oklahoma City, OK 73120
US
Alvarez, Richard
4817 Clipper Crossing
Edmond, OK 73013
US
Kawar, Ziad
2800 NW 46th St.
Oklahoma City, OK 73112
US
Information about Fees
Click here to load the fees